Stay updated on GLPG2451 and GLPG2222 Combination in CF Clinical Trial
Sign up to get notified when there's something new on the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page.

Latest updates to the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment is now closed, and new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study) have been added to the study page, alongside a formatting update to the Intervention/Treatment heading and the page revision to v3.6.0.SummaryDifference0.4%

- Check16 days agoChange DetectedThe page now shows revision: v3.5.5, replacing v3.5.4. This reflects an updated version of the study record's metadata.SummaryDifference0.0%

- Check31 days agoChange DetectedLakefront Biotherapeutics NV is now listed as sponsor, replacing Galapagos NV. This indicates a shift in the organization responsible for the trial's conduct and governance.SummaryDifference0.2%

- Check38 days agoChange DetectedThe study record shows a new revision identifier, updating from v3.5.3 to v3.5.4, indicating a minor update to the ClinicalTrials.gov entry.SummaryDifference0.0%

- Check60 days agoChange DetectedThe site’s interface/version revision marker at the bottom of the page was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to GLPG2451 and GLPG2222 Combination in CF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page.